# Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH

> **NCT06832800** · EARLY_PHASE1 · RECRUITING · sponsor: **Women's Hospital School Of Medicine Zhejiang University** · enrollment: 250 (estimated)

## Conditions studied

- Neonatal Hyperbilirubinemia

## Interventions

- **COMBINATION_PRODUCT:** MDT
- **OTHER:** control (current management)

## Key facts

- **NCT ID:** NCT06832800
- **Lead sponsor:** Women's Hospital School Of Medicine Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-21
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06832800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06832800, "Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH". Retrieved via AI Analytics 2026-09-11 from https://api.ai-analytics.org/clinical/NCT06832800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*